IN2014MN02418A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN02418A IN2014MN02418A IN2418MUN2014A IN2014MN02418A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A IN 2418MUN2014 A IN2418MUN2014 A IN 2418MUN2014A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A
- Authority
- IN
- India
- Prior art keywords
- methods
- breast cancer
- subject
- gene expression
- evaluating
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 6
- 206010006187 Breast cancer Diseases 0.000 abstract 5
- 208000026310 Breast neoplasm Diseases 0.000 abstract 5
- 230000014509 gene expression Effects 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000002493 microarray Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000003753 real-time PCR Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261650209P | 2012-05-22 | 2012-05-22 | |
| US201361753673P | 2013-01-17 | 2013-01-17 | |
| PCT/US2013/042157 WO2013177245A2 (en) | 2012-05-22 | 2013-05-22 | Nano46 genes and methods to predict breast cancer outcome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02418A true IN2014MN02418A (pl) | 2015-08-14 |
Family
ID=49624503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2418MUN2014 IN2014MN02418A (pl) | 2012-05-22 | 2013-05-22 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20130337444A1 (pl) |
| EP (1) | EP2852689B1 (pl) |
| JP (1) | JP6325530B2 (pl) |
| CN (2) | CN104704128A (pl) |
| AU (1) | AU2013266419B2 (pl) |
| BR (1) | BR112014029300A2 (pl) |
| CA (1) | CA2874492C (pl) |
| ES (1) | ES2763931T3 (pl) |
| IL (1) | IL235795B (pl) |
| IN (1) | IN2014MN02418A (pl) |
| MX (1) | MX369628B (pl) |
| WO (1) | WO2013177245A2 (pl) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20140140T1 (en) | 2008-05-30 | 2014-05-23 | The University Of North Carolina At Chapel Hill | Gene expression profiles to predict breast cancer outcomes |
| WO2012125828A2 (en) | 2011-03-15 | 2012-09-20 | The University Of North Carolina At Chapell Hill | Methods of treating breast cancer with anthracycline therapy |
| GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| EP2785873A4 (en) | 2011-11-30 | 2015-11-11 | Univ North Carolina | METHOD FOR THE TREATMENT OF BREAST CANCER WITH TAXAN THERAPY |
| USRE50065E1 (en) | 2012-10-17 | 2024-07-30 | 10X Genomics Sweden Ab | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
| WO2014186349A1 (en) * | 2013-05-13 | 2014-11-20 | Nanostring Technologies, Inc. | Methods to predict risk of recurrence in node-positive early breast cancer |
| CN105849275B (zh) | 2013-06-25 | 2020-03-17 | 普罗格诺西斯生物科学公司 | 检测样品中生物靶标的空间分布的方法和系统 |
| EP3044332A1 (en) | 2013-09-09 | 2016-07-20 | British Columbia Cancer Agency Branch | Methods and kits for predicting outcome and methods and kits for treating breast cancer with radiation therapy |
| CN113403373B (zh) | 2014-11-21 | 2025-04-11 | 布鲁克空间生物学公司 | 无酶且无扩增的测序 |
| US10246700B2 (en) * | 2014-11-24 | 2019-04-02 | Nanostring Technologies, Inc. | Methods and apparatuses for gene purification and imaging |
| EP3230466A1 (en) * | 2014-12-09 | 2017-10-18 | King's College London | Breast cancer treatment with taxane therapy |
| HK1250245A1 (zh) | 2015-04-10 | 2018-12-07 | Spatial Transcriptomics Ab | 生物样本的空间区别、多重核酸分析 |
| WO2017014694A1 (en) * | 2015-07-23 | 2017-01-26 | National University Of Singapore | Wbp2 as a co-prognostic factor with her2 for stratification of patients for treatment |
| EP3458601B1 (en) | 2016-05-16 | 2023-07-05 | Nanostring Technologies, Inc. | Methods for detecting target nucleic acids in a sample |
| EP4050112A1 (en) | 2016-06-21 | 2022-08-31 | 10X Genomics, Inc. | Nucleic acid sequencing |
| WO2018074865A2 (ko) * | 2016-10-21 | 2018-04-26 | 서울대학교병원 | 유방암 예후 예측용 조성물 및 방법 |
| JP6730525B2 (ja) | 2016-11-21 | 2020-07-29 | ナノストリング テクノロジーズ，インコーポレイティド | 化学組成物とそれを利用する方法 |
| KR101950717B1 (ko) * | 2016-11-23 | 2019-02-21 | 주식회사 젠큐릭스 | 유방암 환자의 화학치료 유용성 예측 방법 |
| US11978535B2 (en) * | 2017-02-01 | 2024-05-07 | The Translational Genomics Research Institute | Methods of detecting somatic and germline variants in impure tumors |
| EP4589017A3 (en) | 2017-10-06 | 2025-10-08 | 10x Genomics, Inc. | Rna templated ligation |
| KR102071491B1 (ko) * | 2017-11-10 | 2020-01-30 | 주식회사 디시젠 | 차세대 염기서열분석을 이용한 기계학습 기반 유방암 예후 예측 방법 및 예측 시스템 |
| JP7525402B2 (ja) | 2018-05-14 | 2024-07-30 | ナノストリング テクノロジーズ，インコーポレイティド | 化学的組成物とそれを利用する方法 |
| US20210371936A1 (en) * | 2018-11-05 | 2021-12-02 | Biontech Diagnostics Gmbh | Predictive methods in breast cancer |
| SG11202111878RA (en) | 2019-05-31 | 2021-11-29 | 10X Genomics Inc | Method of detecting target nucleic acid molecules |
| JP7352937B2 (ja) * | 2019-07-19 | 2023-09-29 | 公立大学法人福島県立医科大学 | 乳癌のサブタイプを鑑別又は分類するための鑑別マーカー遺伝子セット、方法およびキット |
| GB201919032D0 (en) | 2019-12-20 | 2020-02-05 | Cartana Ab | Method of detecting an analyte |
| EP4107285B1 (en) | 2020-02-21 | 2024-10-09 | 10X Genomics, Inc. | Methods and compositions for integrated in situ spatial assay |
| US12209273B2 (en) | 2020-06-12 | 2025-01-28 | 10X Genomics, Inc. | Nucleic acid assays using click chemistry bioconjugation |
| EP3945136A1 (en) * | 2020-07-28 | 2022-02-02 | Hospital Clínic de Barcelona | In vitro method for the prognosis of patients suffering from her2-positive breast cancer |
| US12297499B2 (en) | 2020-08-17 | 2025-05-13 | 10X Genomics, Inc. | Multicomponent nucleic acid probes for sample analysis |
| US12060603B2 (en) | 2021-01-19 | 2024-08-13 | 10X Genomics, Inc. | Methods for internally controlled in situ assays using padlock probes |
| JP2024543736A (ja) * | 2021-12-20 | 2024-11-22 | リヴィール ゲノミクス エセ．エレ | ＨＥＲ２陽性乳癌を患う患者の予後診断を行うｉｎ ｖｉｔｒｏ方法の開発及び検証 |
| CN117965734B (zh) * | 2024-02-02 | 2024-09-24 | 奥明星程(杭州)生物科技有限公司 | 一种用于检测硬纤维瘤的基因标志物、试剂盒、检测方法及应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| JP2001524926A (ja) | 1991-09-18 | 2001-12-04 | アフィマックス テクノロジーズ ナームロゼ フェンノートシャップ | オリゴマーの雑多ライブラリーの集合体を合成する方法 |
| ATE262374T1 (de) | 1991-11-22 | 2004-04-15 | Affymetrix Inc | Kombinatorische strategien für polymersynthese |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
| ATE291097T1 (de) | 1997-10-31 | 2005-04-15 | Affymetrix Inc A Delaware Corp | Expressionsprofile in adulten und fötalen organen |
| US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| US6750015B2 (en) * | 2000-06-28 | 2004-06-15 | Kathryn B. Horwitz | Progesterone receptor-regulated gene expression and methods related thereto |
| US20020168639A1 (en) * | 2000-09-22 | 2002-11-14 | Muraca Patrick J. | Profile array substrates |
| JP4680898B2 (ja) * | 2003-06-24 | 2011-05-11 | ジェノミック ヘルス， インコーポレイテッド | 癌再発の可能性の予測 |
| US20050071087A1 (en) * | 2003-09-29 | 2005-03-31 | Anderson Glenda G. | Systems and methods for detecting biological features |
| WO2006010150A2 (en) | 2004-07-15 | 2006-01-26 | University Of Utah Research Foundation | Housekeeping genes and methods for identifying the same |
| CN101061480A (zh) * | 2004-09-22 | 2007-10-24 | 三路影像公司 | 用来分析和优化用于癌症诊断的标记候选物的方法和计算机程序产品 |
| WO2007061876A2 (en) | 2005-11-23 | 2007-05-31 | University Of Utah Research Foundation | Methods and compositions involving intrinsic genes |
| CA2635215C (en) | 2005-12-23 | 2016-08-30 | Nanostring Technologies, Inc. | Compositions comprising oriented, immobilized macromolecules and methods for their preparation |
| CA2640385C (en) | 2005-12-23 | 2014-07-15 | Nanostring Technologies, Inc. | Nanoreporters and methods of manufacturing and use thereof |
| WO2008124847A2 (en) | 2007-04-10 | 2008-10-16 | Nanostring Technologies, Inc. | Methods and computer systems for identifying target-specific sequences for use in nanoreporters |
| WO2008150512A2 (en) * | 2007-06-04 | 2008-12-11 | University Of Louisville Research Foundation, Inc. | Methods for identifying an increased likelihood of recurrence of breast cancer |
| EP2195467B1 (en) * | 2007-09-06 | 2016-12-14 | bioTheranostics, Inc. | Tumor grading and cancer prognosis in breast cancer |
| HRP20140140T1 (en) * | 2008-05-30 | 2014-05-23 | The University Of North Carolina At Chapel Hill | Gene expression profiles to predict breast cancer outcomes |
| WO2010019826A1 (en) | 2008-08-14 | 2010-02-18 | Nanostring Technologies, Inc | Stable nanoreporters |
| CN102971435B (zh) * | 2010-03-31 | 2016-05-11 | 斯维丹诊断有限责任公司 | 用于内分泌治疗下的乳腺癌复发预测的方法 |
-
2013
- 2013-05-22 EP EP13794236.3A patent/EP2852689B1/en active Active
- 2013-05-22 WO PCT/US2013/042157 patent/WO2013177245A2/en not_active Ceased
- 2013-05-22 US US13/899,656 patent/US20130337444A1/en not_active Abandoned
- 2013-05-22 IN IN2418MUN2014 patent/IN2014MN02418A/en unknown
- 2013-05-22 JP JP2015514143A patent/JP6325530B2/ja active Active
- 2013-05-22 BR BR112014029300A patent/BR112014029300A2/pt not_active Application Discontinuation
- 2013-05-22 ES ES13794236T patent/ES2763931T3/es active Active
- 2013-05-22 CN CN201380038875.4A patent/CN104704128A/zh active Pending
- 2013-05-22 MX MX2014014275A patent/MX369628B/es active IP Right Grant
- 2013-05-22 CN CN201911216650.9A patent/CN111500718A/zh active Pending
- 2013-05-22 CA CA2874492A patent/CA2874492C/en active Active
- 2013-05-22 AU AU2013266419A patent/AU2013266419B2/en active Active
-
2014
- 2014-11-20 IL IL235795A patent/IL235795B/en active IP Right Grant
-
2020
- 2020-02-14 US US16/792,051 patent/US20200332368A1/en not_active Abandoned
-
2022
- 2022-09-29 US US17/936,745 patent/US20230272476A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20230272476A1 (en) | 2023-08-31 |
| CN111500718A (zh) | 2020-08-07 |
| WO2013177245A3 (en) | 2015-01-29 |
| JP6325530B2 (ja) | 2018-05-16 |
| AU2013266419B2 (en) | 2018-09-27 |
| CN104704128A (zh) | 2015-06-10 |
| US20130337444A1 (en) | 2013-12-19 |
| AU2013266419A1 (en) | 2014-12-11 |
| IL235795A0 (en) | 2015-01-29 |
| MX2014014275A (es) | 2015-07-06 |
| JP2015518724A (ja) | 2015-07-06 |
| WO2013177245A2 (en) | 2013-11-28 |
| US20200332368A1 (en) | 2020-10-22 |
| BR112014029300A2 (pt) | 2017-07-25 |
| CA2874492A1 (en) | 2013-11-28 |
| EP2852689B1 (en) | 2019-12-11 |
| EP2852689A4 (en) | 2016-05-11 |
| MX369628B (es) | 2019-11-14 |
| IL235795B (en) | 2020-02-27 |
| CA2874492C (en) | 2021-10-19 |
| EP2852689A2 (en) | 2015-04-01 |
| ES2763931T3 (es) | 2020-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN02418A (pl) | ||
| CY1114993T1 (el) | Προφιλ εκφρασης γονιδιου για να προβλεπονται εκβασεις καρκινου μαστου | |
| MX2019007814A (es) | Algoritmo de perfil de expresion genica y prueba para determinar la prognosis de cancer de prostata. | |
| EP2663656A1 (en) | Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment | |
| WO2013006443A3 (en) | Discovery of a somatic mutation in myd88 gene in lymphoplasmacytic lymphoma | |
| EA201370063A1 (ru) | Фосфолипидом рака | |
| NZ709167A (en) | Compositions and methods for diagnosing thyroid tumors | |
| NZ599194A (en) | Methods to predict clinical outcome of cancer | |
| NZ621638A (en) | Dna methylation in colorectal and breast cancer diagnostic methods | |
| PH12014502410A1 (en) | Breast cancer prognosis, prediction of progesterone receptor subtype and|prediction of response to antiprogestin treatment based on gene expression | |
| HK1222888A1 (zh) | 预测在淋巴结阳性早期乳癌复发风险的方法 | |
| MX2013008252A (es) | Firma de pronostico para la recurrencia de cancer colorrectal. | |
| BR112015022977A2 (pt) | métodos para predição de risco de metástase em melanoma cutâneo | |
| WO2016066797A3 (en) | Prognostic grouping of ovarian cancer patients | |
| RU2010149541A (ru) | Способ прогнозирования развития метаболического синдрома у пациента с абдоминальным ожирением | |
| Eapen | Relapsed acute lymphoblastic leukemia: Is it crucial to achieve molecular remission prior to transplant? | |
| WO2013010140A3 (en) | Methods of diagnosing cancer | |
| MX2017004816A (es) | Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa. | |
| HK1199097A1 (zh) | 用於癌症治疗的预测物 | |
| UA108260U (uk) | Спосіб прогнозування розвитку остеопорозу | |
| UA95616U (uk) | Спосіб прогнозування зрощення перелому | |
| Brennan | Quantifying Biomarker Risks and Benefits | |
| Campbell | Next Generation DNA Sequencing: First Results in Breast Cancer | |
| Sotiriou et al. | Gene Expression Profiling of Breast Cancer: Past and Future | |
| Ellis | Whole Genome Sequencing for Luminal-Type Breast Cancer |